[{"Assets_0_Q2_USD":239076000.0,"CommonStockSharesOutstanding_0_Q2_shares":68976036.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-58667000.0,"NetIncomeLoss_1_Q2_USD":-31671000.0,"NetIncomeLoss_2_Q2_USD":-67791000.0,"StockholdersEquity_0_Q2_USD":138647000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q2_USD":37306000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_2_Q2_USD":64977000.0,"Ticker":"NVTA","CIK":"1501134","name":"INVITAE CORP","OfficialName":"Invitae Corporation Common Stock","form":"10-Q","period":"20180630","fy":"2018.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1411245815.0","Country":"United States","Sector":"Health Care","Industry":"Medical Specialities","Market":"NYSE","SP500":"nan","filed":"20180809"}]